-
Je něco špatně v tomto záznamu ?
Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma
I Kawaciuk, L Hyrsl, P Dusek, L Jarolim, M Schmidt, V Kaliska, M Chocholaty, S Vesely
Jazyk angličtina Země Švédsko
- MeSH
- diagnostické zobrazování MeSH
- karcinom z renálních buněk diagnóza chirurgie mortalita patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití MeSH
- nádory ledvin diagnóza chirurgie mortalita patologie MeSH
- náhodný nález MeSH
- nefrektomie MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- senioři MeSH
- staging nádorů MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
OBJECTIVE: To evaluate the prognostic significance of symptoms related to renal cell carcinoma (RCC) in comparison with incidentally detected tumours in a group of long-term observed patients. MATERIAL AND METHODS: The study included 396 patients operated for RCC between 1982 and 2001. The patients were classified according to age, gender, detection mode, pathological stage and grade, tumour size, nodal involvement and Eastern Cooperative Oncology Group (ECOG) performance status. Special attention was given to the analysis of duration and quality of symptoms. The endpoint of the study was overall survival, which was assessed with univariate and multivariate analyses using the Kaplan-Meier method, log-rank test and Cox proportional hazards model. RESULTS: Of the 396 patients, 135 (34%) and 261 (66%) presented with incidental and symptomatic RCC, respectively. Compared with incidental cases, symptomatic tumours had significantly larger size (p < 0.0001), and higher pathological stage (p < 0.0001) and grade (p < 0.02). Five-year survival in patients with incidental and symptomatic tumours was 88.1% and 59.4% (p < 0.0001), respectively. In relation to the quality of symptoms, the 5-year survival in patients with local and systemic symptoms was 75.4% and 44.4% (p < 0.0001), respectively. In the group of patients with a history of tumour-related symptoms shorter and longer than 3 months, the 5-year survival was 62.2% and 55.6% (p < 0.0001), respectively. Multivariate analysis found tumour size [hazard ratio (HR) 1.22, p = 0.05] tumour grade (HR 1.44, p = 0.002), tumour stage (HR 1.35, p = 0.001), presence of symptoms (HR 1.36, p = 0.004) and ECOG (HR 1.25, p = 0.005) to be independent prognostic variables. CONCLUSION: Preoperative somatic symptoms and performance status in patients with RCC provide readily available prognostic information in addition to tumour size, stage and grade.
Citace poskytuje Crossref.org
- 000
- 02121naa 2200529 a 4500
- 001
- bmc11006340
- 003
- CZ-PrNML
- 005
- 20121203100337.0
- 008
- 110401s2008 sw e eng||
- 009
- AR
- 024 __
- $a 10.1080/00365590802022151 $2 doi
- 035 __
- $a (PubMed)18932106
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Kawaciuk, Ivan, $d 1944-2020 $7 nlk20000080917
- 245 10
- $a Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma / $c I Kawaciuk, L Hyrsl, P Dusek, L Jarolim, M Schmidt, V Kaliska, M Chocholaty, S Vesely
- 314 __
- $a Department of Urology, 2nd Faculty of Medicine, University Hospital in Motol, Prague, Czech Republic. ivan.kawaciuk@lfmotol.cuni.cz
- 520 9_
- $a OBJECTIVE: To evaluate the prognostic significance of symptoms related to renal cell carcinoma (RCC) in comparison with incidentally detected tumours in a group of long-term observed patients. MATERIAL AND METHODS: The study included 396 patients operated for RCC between 1982 and 2001. The patients were classified according to age, gender, detection mode, pathological stage and grade, tumour size, nodal involvement and Eastern Cooperative Oncology Group (ECOG) performance status. Special attention was given to the analysis of duration and quality of symptoms. The endpoint of the study was overall survival, which was assessed with univariate and multivariate analyses using the Kaplan-Meier method, log-rank test and Cox proportional hazards model. RESULTS: Of the 396 patients, 135 (34%) and 261 (66%) presented with incidental and symptomatic RCC, respectively. Compared with incidental cases, symptomatic tumours had significantly larger size (p < 0.0001), and higher pathological stage (p < 0.0001) and grade (p < 0.02). Five-year survival in patients with incidental and symptomatic tumours was 88.1% and 59.4% (p < 0.0001), respectively. In relation to the quality of symptoms, the 5-year survival in patients with local and systemic symptoms was 75.4% and 44.4% (p < 0.0001), respectively. In the group of patients with a history of tumour-related symptoms shorter and longer than 3 months, the 5-year survival was 62.2% and 55.6% (p < 0.0001), respectively. Multivariate analysis found tumour size [hazard ratio (HR) 1.22, p = 0.05] tumour grade (HR 1.44, p = 0.002), tumour stage (HR 1.35, p = 0.001), presence of symptoms (HR 1.36, p = 0.004) and ECOG (HR 1.25, p = 0.005) to be independent prognostic variables. CONCLUSION: Preoperative somatic symptoms and performance status in patients with RCC provide readily available prognostic information in addition to tumour size, stage and grade.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a karcinom z renálních buněk $x diagnóza $x chirurgie $x mortalita $x patologie $7 D002292
- 650 _2
- $a diagnostické zobrazování $7 D003952
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a náhodný nález $7 D033162
- 650 _2
- $a nádory ledvin $x diagnóza $x chirurgie $x mortalita $x patologie $7 D007680
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a nefrektomie $7 D009392
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $7 D015996
- 700 1_
- $a Hyršl, Lubomír, $d 1934- $7 nlk20000080920
- 700 1_
- $a Dušek, Pavel $7 xx0069989
- 700 1_
- $a Jarolím, Ladislav, $d 1949- $7 jn20010310079
- 700 1_
- $a Schmidt, Marek $7 xx0105483
- 700 1_
- $a Šturcová Kaliská, Veronika $7 xx0080464
- 700 1_
- $a Chocholatý, Matúš $7 xx0121519
- 700 1#
- $a Veselý, Štěpán. $7 xx0208977
- 773 0_
- $t Scandinavian Journal of Urology & Nephrology $w MED00010606 $g Roč. 42, č. 5 (2008), s. 406-411 $x 0036-5599
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110414103749 $b ABA008
- 991 __
- $a 20121203100408 $b ABA008
- 999 __
- $a ok $b bmc $g 833942 $s 698438
- BAS __
- $a 3
- BMC __
- $a 2008 $b 42 $c 5 $d 406-411 $i 0036-5599 $m Scandinavian journal of urology and nephrology $n Scand J Urol Nephrol $x MED00010606
- LZP __
- $a 2011-1B09/jjme